ArticleFrontiers in pharmacology2022

Ribociclib Inhibits P-gp-Mediated Multidrug Resistance in Human Epidermoid Carcinoma Cells.

Lei Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.